This is reflected in section 4.2, 4.4 and 5.2 of the SPC. • 4.3 Contraindication Due to a marked reduction in atazanavir trough concentrations observed during concomitant use of omeprazole, use of PPIs is contraindicated in the SPC for Rayataz (atazanavir).